Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1977
Reactivity to SV40 T antigen in athymic (nude), anti-thymocyte serum-treated, and normal mice
B B Knowles, S R Ford, D P Aden
The Journal of Biological Chemistry
|
June 10, 1983
Characterization of the human plasma binding protein for vitamin D and its metabolites synthesized by the human hepatoma-derived cell line, Hep 3B
J G Haddad, D P Aden, M A Kowalski
Cellular Immunology
|
November 1, 1974
Exclusion of cooperating T cells as targets for heterologous anti-mu antiserum
D P Aden, D D Manning, N D Reed
Science (New York, N.Y.)
|
July 25, 1980
Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen
B B Knowles, C C Howe, D P Aden
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
June 1, 1972
Reconstitution of the in vitro immune response of congenitally thymusless (nude) mice
D P Aden, N D Reed, J W Jutila
Transplantation Proceedings
|
March 1, 1977
Cytotoxic cell-mediated response to tumor antigens on somatic cell hybrids
G Trinchieri, D P Aden, D Solter, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1981
Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line
M S Khan, B B Knowles, D P Aden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1982
Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines
H Saito, L T Goodnough, B B Knowles, et al.
Nature
|
December 6, 1979
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
D P Aden, A Fogel, S Plotkin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1983
Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein
A C Moses, A J Freinkel, B B Knowles, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1977
Reactivity to SV40 T antigen in athymic (nude), anti-thymocyte serum-treated, and normal mice
B B Knowles, S R Ford, D P Aden
The Journal of Biological Chemistry
|
June 10, 1983
Characterization of the human plasma binding protein for vitamin D and its metabolites synthesized by the human hepatoma-derived cell line, Hep 3B
J G Haddad, D P Aden, M A Kowalski
Cellular Immunology
|
November 1, 1974
Exclusion of cooperating T cells as targets for heterologous anti-mu antiserum
D P Aden, D D Manning, N D Reed
Science (New York, N.Y.)
|
July 25, 1980
Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen
B B Knowles, C C Howe, D P Aden
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
June 1, 1972
Reconstitution of the in vitro immune response of congenitally thymusless (nude) mice
D P Aden, N D Reed, J W Jutila
Transplantation Proceedings
|
March 1, 1977
Cytotoxic cell-mediated response to tumor antigens on somatic cell hybrids
G Trinchieri, D P Aden, D Solter, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1981
Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line
M S Khan, B B Knowles, D P Aden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1982
Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines
H Saito, L T Goodnough, B B Knowles, et al.
Nature
|
December 6, 1979
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
D P Aden, A Fogel, S Plotkin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 1, 1983
Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein
A C Moses, A J Freinkel, B B Knowles, et al.
Page
of 4